Sumary of COVID Antibody Treatment Is Safe, Effective in Transplant Patients:
- Said senior author Dr. Raymund Razonable, an infectious diseases specialist at the Mayo Clinic in Rochester, Minn..
- None required mechanical ventilation, died or developed organ rejection, according to findings published June 10 in the journal Open Forum Infectious Diseases..
- Food and Drug Administration authorized emergency use of the monoclonal antibody therapies bamlanivimab and casirivimab-imdevimab to treat mild to moderate COVID in patients at high risk for serious illness..
- But many health care institutions hesitated to use them because their safety and effectiveness for transplant patients was unknown due to limited clinical data, Razonable said…